OTILIMAB

UNII:	Y8127R3VCH
Formula:
Preferred Substance Name:	OTILIMAB

1638332-55-4
GSK3196165
GSK-3196165
IMMUNOGLOBULIN G1, ANTI-(HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR) (HUMAN MONOCLONAL GSK3196165 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL GSK3196165 .LAMBDA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF, CSF))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-447) (HUMAN VH (HOMO SAPIENS IGHV3-NL1*01 (88%) (IGHD)-IGHJ1*01) (8.10.8) (1-117) -HOMO SAPIENS IGHG1*03 (118-447)) (220-209')-DISULFIDE WITH LAMBDA LIGHT CHAIN (1'-210') (HUMAN V-LAMBDA (HOMO SAPIENS IGLV3-1*01 (88%) IGLJ3*02) (6.1.9) (1'-104') -HOMO SAPIENS IGLC2*01 (105'-210')) DIMER (226-226'':229-229'')-BISDISULFIDE
MOR103
MOR-103
OTILIMAB [INN]
OTILIMAB [JAN]
OTILIMAB [USAN]
OTILIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

OTILIMAB

Synonyms and Mappings

Resources